Skip to main contentrtttttt Skip to main content
Integrative Psychiatry

Emotions as Intelligence

In our American culture of to-do lists, we rely on our brains to regulate our behaviors and get things done. It is easy to imagine ourselves as brains that exist in this world, forgetting that we are so much more. For one, we have bodies that hold richly complex information in the form of sensation, intuition, and emotion. Emotion is a type of intelligence that gives us insight into our internal world, a messenger of our conscious and unconscious needs and desires; emotion might be thought of as feedback from our holistic selves, a voice of alignment/misalignment across all of our parts, including our spiritual selves.

What is Emotional Intelligence?

Emotional intelligence is an empowering skillset for navigating the self through a life that is ever-changing. Emotional intelligence is often advertised in the workplace, yet is more than just the ability to manage emotions in professional settings; it embodies a deep understanding and acceptance of a person’s inner landscape. Rather than viewing emotions as uncomfortable obstacles to be suppressed or controlled, emotional intelligence invites individuals to explore feelings and their corresponding needs with vulnerability, openness, and nonjudgement; thus, emotional intelligence supports self-awareness, self-regulation, and self-actualization. Speaking from a place of heart-centered communication also encourages the cultivation of genuine connections with others. 

Understanding Emotional Information

Below are some useful ways to conceptualize different emotions and the information they may be imparting, according to Karla McLaren (2010). These emotions and their “interpretations” are not exhaustive or conclusive, a reminder that deriving personal meaning is what matters. Emotions are tricky in that development and culture has a lot to do with how and when an individual feels, processes, and expresses them. Emotions are also complex, a person often feeling multiple at once. Listening to and discerning emotions requires self-compassionate awareness; a therapist may be able to assist in reflecting, naming, sorting, and understanding emotions.

Anger: Feeling anger can help set external boundaries around something valuable that needs to be protected. It may provide information about someone else’s behavior, initiating avoidance or healthy confrontation to address what needs to be safeguarded or restored.

Shame: The other side of the coin to anger is shame (anger towards self), arising to support the creation of internal boundaries and supporting a change in personal behavior to become more aligned with the authentic self.

Sadness/Grief: Sadness is an emotion that often communicates a need for social support. The feeling of sadness may be an indication of letting go of something and creating space for growth.

Fear/Anxiety: Fear may be a source of inner wisdom, an alertness arising from instincts that provides information to inspire nervous system activation and movement, such as an action that might need to be taken.

Happiness: Feelings related to happiness might signify that certain needs are currently being met. It is the guiding light toward making inner and outer worlds more congruent, the “yes” that motivates repeated behaviors. While happiness is sought out due to its restful and nourishing qualities, it is important to acknowledge the necessity of other emotions and the profound insights they offer.

Citation:

McLaren, K. (2010). The language of emotions: What your feelings are trying to tell you (Rev. ed. 2023). Sounds True.

Sara Reed, MS, LMFT

Sara Reed is a Licensed Marriage and Family Therapist and CEO of Mind’s iHealth Solutions, a digital health company that provides evidence based and culturally responsible mental health services for underserved groups. As a mental health futurist and clinical researcher, Sara examines the ways culture informs the way we diagnose and treat mental illness. Sara’s prior research work includes participation as a study therapist in psychedelic therapy research at Yale University and the University of Connecticut’s Health Center. Sara was the first Black therapist to provide MDMA-assisted psychotherapy in a clinical trial and continues to engage in ongoing advocacy work around health equity in psychedelic medicine.

https://psychiatryinstitute.com/wp-content/uploads/2019/11/Jeffrey-Guss.png

Jeffrey Guss, MD is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy and the treatment of substance use disorders. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psychedelic-assisted psychotherapy in the treatment of cancer-related existential distress, which was published in Journal of Psychopharmacology, 2016. He currently is a study therapist in the NYU study on Psychedelic-Assisted therapy in the treatment of Alcoholism, a collaborator with Yale University’s study on psychedelic-assisted therapy for Major Depressive Disorder and a study therapist with the MAPS (Multidisciplinary Association for Psychedelic Studies) study on treatment of Post Traumatic Stress Disorder with Psychedelic-Assisted Psychotherapy. 

Dr. Guss is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture and Society. He has published (with Elizabeth Nielson, PhD) a paper on “the influence of therapists’ first had experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training” in The Journal of Psychedelic Studies, August, 2018. He is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies and Supervisor in NYU’s Fellowship in Addiction Psychiatry. 

Dr. Guss maintains a private practice in New York City.

Will Van Derveer, MD

Will Van Derveer, MD is Co-Founder of Integrative Psychiatry Institute and Integrative Psychiatry Centers. Dr. Van Derveer was co-investigator on a phase 2 MAPS study of Psychedelic-assisted psychotherapy for treatment-resistant PTSD, and co-authored the publication of this study in 2018. He has also provided Psychedelic-assisted psychotherapy in two MAPS training studies. An active provider of KAP at his clinic in Boulder, CO, he has been teaching others KAP therapy for several years. Dr. Van Derveer contributed a chapter on mescaline in the 2021 "Handbook of Medical Hallucinogens" (edited by Charles Grob and Jim Grigsby). He is co-host of the Higher Practice Podcast.

Dr. Van Derveer regards unresolved emotional trauma as the most significant under-recognized root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass.


Scott has been a student of consciousness since his honors thesis on that topic at the University of Arizona in the 1970s under the tutelage of Dr. Andrew Weil. Following medical school, Scott studied Jungian therapy and acupuncture while working as a primary care physician in a rural area for four years. Psychedelic-assisted psychotherapy became a facet of his practice before this medicine was scheduled in 1985. He then completed a psychiatry residency at Columbia program in New York. Scott studied cross-cultural psychiatry and completed a child/adolescent psychiatry fellowship at the University of New Mexico.

In 2010 he founded Wholeness Center in Fort Collins. This innovative clinic provides cross-disciplinary evaluation and care for all mental health concerns. Scott serves as a site Principal Investigator and therapist for the Phase III trial of psychedelic-assisted psychotherapy for PTSD sponsored by (MAPS). He has also published numerous articles about his research on (CBD) in mental health. Currently, Scott works extensively with psychedelic-assisted-psychotherapy. He lectures all over the world to professional groups interested in a deeper look at mental health issues, safer tools, and a paradigm-shifting perspective about transformative care.

Will Van Derveer, MD is co-founder of Integrative Psychiatry Institute (IPI), along with friend and colleague Keith Kurlander, MA. He co-created IPI as an expression of what he stands for. First, that anyone can heal, and second that we medical providers must embrace our own healing journeys in order to fully command our potency as healers.

Dr. Van Derveer spent the last 20 years innovating and testing a comprehensive approach to addressing psychiatric challenges which transcends the conventional model he learned in medical school at Vanderbilt University and residency at University of Colorado, while deeply engaging his own healing path.

He founded the Integrative Psychiatric Healing Center in in 2001 in Boulder, CO, where he currently practices. Dr. Van Derveer regards unresolved emotional trauma as the most significant root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass. In addition to his clinical work and teaching, he was co-investigator in 2016 a Phase II randomized clinical trial, sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). He continues to support this protocol, now in a Phase III clinical trial under break-through designation by FDA.

Dr. Van Derveer is a diplomate of the American Board of Integrative and Holistic Medicine (ABoIHM) since 2013, and he was board certified in the first wave of diplomates of the new American Board of Integrative Medicine (ABIM) in 2016.